Oral Iron for Erythropoietic Protoporphyrias

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

July 19, 2019

Study Completion Date

July 19, 2019

Conditions
Erythropoietic ProtoporphyriaEPPX-linked ProtoporphyriaXLP
Interventions
DRUG

Oral Iron

for one year

Trial Locations (6)

10029

Icahn School of Medicine at Mount Sinai, New York

27106

Wake Forest University Health Sciences, Winston-Salem

35294

University of Alabama, Birmingham, Birmingham

77555

University of Texas Medical Branch, Galveston

84132

University of Utah, Salt Lake City

94143

University of California, San Francisco

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02979249 - Oral Iron for Erythropoietic Protoporphyrias | Biotech Hunter | Biotech Hunter